Targeting Ferroptosis to Fight Breast Cancer Drug Resistance
Author Information
Author(s): Peng Cuixin, Chen Yanning, Jiang Mingzhang
Primary Institution: Department of Pharmacy, West China Xiamen Hospital of Sichuan University, Xiamen, China
Hypothesis
Inducing ferroptosis can help overcome drug resistance in breast cancer.
Conclusion
Therapies that target ferroptosis may provide new hope for breast cancer patients facing drug resistance.
Supporting Evidence
- Ferroptosis is linked to therapeutic efficacy in cancer treatment, especially in breast cancer.
- Inducing ferroptosis can counteract mechanisms of drug resistance in breast cancer.
- Ferroptosis inducers like erastin and sulfasalazine enhance the effectiveness of chemotherapy.
- Triple-negative breast cancer is particularly prone to drug resistance, making ferroptosis a critical target.
- Targeting iron metabolism may help regulate chemotherapy resistance in breast cancer.
Takeaway
Ferroptosis is a way that cancer cells can die, and making them die this way might help doctors treat breast cancer better.
Methodology
This review summarizes recent advancements in understanding ferroptosis and its role in breast cancer drug resistance.
Limitations
The full regulatory network governing ferroptosis is not yet fully understood, and optimal dosages for patients require further exploration.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website